Infarct Evolution on MR-DWI After Thrombectomy in Acute Stroke Patients Randomized to Nerinetide or Placebo.
Joachim C FladtJen GuoJacinta L SpechtMeng WangLeona L ChanRyan MctaggartBrian H BuckRichard I AvivRichard H SwartzThalia Shoshana FieldJason TarpleyRuchir ShahMayank GoyalMichael TymianskiMichael D HillAndrew M DemchukChristopher d'EsterrePhilip A BarberPublished in: Neurology (2023)
This study provides Class II evidence that for patients with acute large vessel ischemic stroke undergoing EVT, nerinetide did not significantly decrease early post-EVT infarct growth compared with placebo.
Keyphrases
- double blind
- phase iii
- placebo controlled
- acute myocardial infarction
- open label
- liver failure
- clinical trial
- atrial fibrillation
- magnetic resonance
- respiratory failure
- phase ii
- drug induced
- magnetic resonance imaging
- randomized controlled trial
- intensive care unit
- hepatitis b virus
- acute coronary syndrome
- extracorporeal membrane oxygenation